Driving innovation through collaboration: development of clinical annotation datasets for brain cancer biobanking

- Gedye, Craig, Sachchithananthan, Mythily, Nowak, Anna K., BCBA Consortium,, Leonard, Robyn, Jeffree, Rosalind L., Buckland, Michael E., Ziegler, David S., Graeber, Manuel B., Day, Bryan W., McDonald, Kerrie L., Lasocki, Arian

Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement

- Valvi, Santosh, Manoharan, Neevika, Mateos, Marion K., Hassall, Timothy E. G., Ziegler, David S., McCowage, Geoffrey B., Dun, Matthew D., Eisenstat, David D., Gottardo, Nicholas G., Hansford, Jordan R.

Parents' experiences of postmortem tumor donation for high-grade gliomas: Benefits and suggested improvements

- Robertson, Eden G., Wakefield, Claire E., Tsoli, Maria, Kellie, Stewart J., Alvaro, Frank, Gifford, Andrew J., Weber, Martin A., Rodriguez, Michael, Kirby, Maria, Ziegler, David S.

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs

- Liu, Pei Y., Sokolowski, Nicholas, Liu, Bing, Yang, Rui H., Guo, Xiang Y., Tee, Andrew E., Itoh, Ken, Wang, Jenny, Kavallaris, Maria, Haber, Michelle, Norris, Murray D., Cheung, Belamy B., Guo, Su T., Byrne, Jennifer A., Ziegler, David S., Marshall, Glenn M., Dinger, Marcel E., Codd, Rachel, Zhang, Xu D., Liu, Tao, Siddiqi, Faraz, Atmadibrata, Bernard, Telfer, Thomas J., Sun, Yuting, Zhang, Lihong, Yu, Denise, Mccarroll, Joshua

Treatment of children with poor risk solid tumors by further escalation of the VETOPEC regimen including very high-dose cyclophosphamide and peripheral stem cell support: an Australian and New Zealand Children's Hematology and Oncology Group Study

- McCowage, Geoffrey B., Mrongovius, Robert, Alvaro, Frank, Cohn, Richard J., Ziegler, David S., Oswald, Cecilia, White, Les, ANZCHOG,